Friedreich Ataxia Genetic Evaluation
Analyzes the FXN gene for pathogenic variants and GAA repeat expansions associated with Friedreich Ataxia (FA) to support accurate diagnosis and clinical evaluation.
Accessed through the FA Identified Sponsored Testing Program•Sponsored by Biogen•Performed by Prevention Genetics
Designed to support clinical decision-making and ordering in your practice.
For healthcare providers
Overview
Sponsored by Biogen, this program offers no-cost genetic testing for Friedreich ataxia (FA) to support diagnosis and evaluation of patients with suspected or confirmed FA. Testing is available for individuals ≥16 years residing in the U.S. or Puerto Rico and must be ordered by a qualified provider.
When to consider this test
Patient selection
- Age: Patient is ≥16 years old.
- Location: Patient resides in the United States or Puerto Rico.
- Clinical criteria: Patient has a suspected or confirmed diagnosis of Friedreich Ataxia (FA).
- Ordering requirements: Testing must be ordered by a licensed health care professional.
Workflow
How to use this program
- 1
Assess Eligibility
Confirm the patient meets program criteria and discuss the purpose, benefits, and limitations of FA genetic testing.
- 2
Order the Test
Submit the order using the test requisition form (TRF). Ensure all required clinical and patient information is complete.
- 3
Collect and Label Specimen
Collect the specimen in the appropriate tube and label with at least two identifiers. Specimens are accepted Monday–Saturday; holiday schedules are posted online.
- 4
Review Results With Patient
Results are returned in about three weeks after the lab receives the specimen and paperwork. Discuss findings with the patient and caregiver as appropriate.
Billing overview
Program billing
For eligible patients, the sponsor has arrangements with the laboratory that may reduce or cover some or all of the patient's out-of-pocket cost. Actual cost and patient responsibility vary by program criteria. Refer to lab or sponsor materials for details.
Quality & privacy
Laboratory quality & data handling
Testing is performed by Prevention Genetics, a CLIA-certified laboratory (CLIA 52D2065132) and College of American Pathologists (CAP) certified laboratory (CAP 7185561). Your sample is processed using validated methods and quality controls to support reliable genetic results.
Your health information is handled under privacy and security practices that are intended to align with applicable regulations. For program- and lab-specific details, review the privacy information provided by the laboratory and sponsor.
FAQ
Frequently asked questions
Which patients are eligible for this program?
Patients aged 16 years or older, residing in the U.S. or Puerto Rico, with a suspected or confirmed diagnosis of Friedreich Ataxia (FA), may qualify. The test must be ordered by a licensed health care provider.
What test is included in the program?
The program covers no-cost testing of the FXN gene for GAA repeat expansions and other pathogenic variants associated with Friedreich Ataxia (FA) to support diagnostic confirmation and risk assessment.
How do I order the test?
Order the test using the program’s test requisition form (TRF), ensuring all required patient and clinical information is completed for processing.
What specimen requirements apply?
Specimens accepted include blood, buccal or saliva. Containers must be labeled with at least two identifiers (patient name, date of birth, ID number). Specimens are accepted Monday–Saturday.
Is genetic counseling available for my patients?
Genetic counseling for patients and families is not included in this program. However, PreventionGenetics genetic counselors are available to review results with ordering providers. You can reach them at +1 715-387-0484 or by email.
How long until results are available?
Results are typically ready in about three weeks after specimen and paperwork receipt.
See an issue with this program?